Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Deficiency, Vitamin E

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Deficiency, Vitamin E in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"The mechanism of 3,4-methylenedioxymethamphetamine (d-MDMA)-induced neurotoxicity may involve formation of toxic radical species."1.31d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity. ( Johnson, EA; Kisin, E; Kommineni, C; Miller, DB; O'Callaghan, JP; Shvedova, AA, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, EA1
Shvedova, AA1
Kisin, E1
O'Callaghan, JP1
Kommineni, C1
Miller, DB1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Deficiency, Vitamin E

ArticleYear
d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.
    Brain research, 2002, Apr-19, Volume: 933, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Animals; Antioxidants; Body Temperature Regulation; Brain; Cell Death;

2002